Dr. Pollack is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
675 N St Clair St
Suite 21-100
Chicago, IL 60611Phone+1 312-695-0990Fax+1 312-695-1144- Is this information wrong?
Summary
- I am a medical oncologist and specialize in treating adult patients with sarcoma. My research is focused on the development of novel immunotherapies for patients with advanced sarcoma, particularly Synovial Sarcoma (SS) and Myxoid/Round Cell Liposarcoma (MRCL). My patient care philosophy is to provide care centered on my patients goals and desires and to fight as hard as I can to help cure my patients.
Education & Training
- University of WashingtonFellowship, Hematology and Medical Oncology, 2008 - 2010
- George Washington UniversityResidency, Internal Medicine, 2005 - 2008
- George Washington University School of Medicine and Health SciencesClass of 2005
- Haverford CollegeBachelor of Arts, Mathematics, 1995 - 1999
Certifications & Licensure
- IL State Medical License 2020 - 2026
- WA State Medical License 2008 - 2022
- VA State Medical License 2005 - 2008
- DC State Medical License 2005 - 2007
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Sig Kohl Legacy Award Northwest Sarcoma Foundation, 2017
Clinical Trials
- Autologous T Cells and Cyclophosphamide in Treating Patients With Soft Tissue Sarcoma That is Metastatic or Cannot Be Removed By Surgery Start of enrollment: 2012 Jan 01
- Recombinant Interferon Gamma in Treating Patients With Soft Tissue Sarcoma Start of enrollment: 2013 Sep 25
- NY-ESO-1 Specific T Cells After Cyclophosphamide in Treating Patients With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma Start of enrollment: 2014 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsImmunotherapy and Radiotherapy Combinations for Sarcoma.Qian S Zhang, John P Hayes, Vinai Gondi, Seth M Pollack> ;Seminars in Radiation Oncology. 2024 Apr 1
- Immune Assessment Today: Optimizing and Standardizing Efforts to Monitor Immune Responses in Cancer and Beyond.Pandey, S., Cholak, M., Yadali, R., Tetreault, M., Fang, D., Gnjatic, S., Obeng, R., Lyerly, H., Sonabend, A., Guevara-Patiño, J., Butterfield, L., Zhang, B., Maecker,...> ;Cancers. 2024 Jan 23
- Pushing forward in sarcoma with a new TCR targeting NY-ESO-1.Rusul Al-Marayaty, Seth M Pollack> ;Cell Reports. Medicine. 2023 Aug 15
- Join now to see all
Press Mentions
- SCCA’s Immunotherapy Leaders Featured at the American Society of Clinical Oncology (ASCO) Annual MeetingMay 31st, 2018
- Can You Vaccinate Yourself Against Cancer?February 21st, 2018
- Cofactor Genomics to Present Immune Profiling Results of Sarcoma Study with the Fred Hutchinson Cancer Research CenterJanuary 9th, 2018
- Join now to see all
Professional Memberships
- Member
- Member
Hospital Affiliations
- Northwestern Memorial HospitalChicago, Illinois
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: